Merck KGaA, Darmstadt, Germany today announced its largest investment in Asia through a ground breaking ceremony of its state ...
Innovent’s phase 3 study of picankibart to treat moderate to severe plaque psoriasis meets all primary and key secondary endpoints: San Francisco Wednesday, May 29, 2024, 13:00 ...
Inspira Technologies’ cardiopulmonary bypass system, Inspira ART100 receives US FDA 510(k) clearance: Ra'anana, Israel Wednesday, May 29, 2024, 16:00 Hrs [IST] Inspira Technolog ...
International Pharmaceutical Federation has launched the FIP-UNESCO UNITWIN Centre for Excellence in the Western Pacific Region. This is a network to advance research, training and curriculum ...
BerGenBio enters clinical trial collaboration with UT Health San Antonio and Sobi: Bergen, Norway Wednesday, May 29, 2024, 18:00 Hrs [IST] BerGenBio ASA, a clinical-stage biopharm ...
CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, announced that it has entered into a multi-year commercial supply ...
Columbia Pacific Communities and KITES Senior Care in merger pact to transform senior healthcare in India: Our Bureau, Bengaluru Wednesday, May 29, 2024, 15:30 Hrs [IST] Columbia ...
MediBuddy, India's largest digital healthcare platform, organised large-scale health check camps in both urban and rural areas across the country, bringing essential preventive care services directly ...
Asahi Kasei to buy Stockholm, Sweden-based Calliditas Therapeutics for SEK 11.8 billion: Chiyoda-ku, Tokyo Wednesday, May 29, 2024, 14:00 Hrs [IST] Asahi Kasei Corp. announces tha ...
ACKO launches ABHA ID feature on app; plans to generate over 1 million IDs by FY25: Our Bureau, Bengaluru Wednesday, May 29, 2024, 15:15 Hrs [IST] ACKO, the insurtech company, has ...
Fischer Medical brings in global healthcare with affordable MRI system made in India: Our Bureau, Bengaluru Wednesday, May 29, 2024, 16:15 Hrs [IST] Fischer Medical Ventures has d ...
Merck’s phase 3 KEYNOTE-522 trial of Keytruda meets its OS endpoint in patients with high-risk early-stage triple negative breast cancer: Rahway, New Jersey Wednesday, May 29, 2 ...